Your browser doesn't support javascript.
loading
Commentary on "Applying CHW method to 2-in-1 design: gain or lose".
Cui, Lu; Hung, H M James; Wang, Sue Jane.
Afiliação
  • Cui L; a Data Statistical Science, AbbVie Inc ., North Chicago , IL , USA.
  • Hung HMJ; b Division of Biometrics I, OB/OTS/CDER, FDA , Silver Spring , MD , USA.
  • Wang SJ; c Office of Biostatistics, OTS/CDER, FDA , Silver Spring , MD , USA.
J Biopharm Stat ; 29(4): 722-727, 2019.
Article em En | MEDLINE | ID: mdl-31258011
ABSTRACT
While 2-in-1 designs give a flexibility to make a clinical trial either an information generation Phase 2 trial or a full scale confirmatory Phase 3 trial, flexible sample size designs can naturally fit into the 2-in-1 design framework. This study is to show that the CHW design can be blended into a 2-in-1 design to improve the adaptive performance of the design. Commenting on the usual 2-in-1 design, we demonstrated that the CHW design can achieve the goal of a 2-in-1 design with satisfactory statistical power and efficient average sample size for a targeted range of the treatment effect.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa Idioma: En Ano de publicação: 2019 Tipo de documento: Article